Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Journey Medical Corporation (DERM) had Debt to Capital Ratio of 0.55 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$56.13M |
|
$-14.67M |
|
$20.88M |
|
$35.26M |
|
$69.81M |
|
$-13.68M |
|
$-0.93M |
|
$-14.61M |
|
$-14.61M |
|
$-14.67M |
|
$-14.67M |
|
$-14.67M |
|
$-14.67M |
|
$-13.68M |
|
$-9.95M |
|
20.43M |
|
20.43M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$48.18M |
|
-- |
|
$32.06M |
|
$80.24M |
|
$35.17M |
|
$24.88M |
|
$25.00M |
|
$60.17M |
|
$20.07M |
|
$-11.79M |
|
$20.07M |
|
22.15M |
|
| Cash Flow Statement Financials | |
$-9.13M |
|
$-15.00M |
|
$16.99M |
|
$27.44M |
|
$20.30M |
|
$-7.13M |
|
$6.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.55 |
1.24 |
|
62.81% |
|
-24.36% |
|
-24.36% |
|
-17.72% |
|
-26.03% |
|
-26.14% |
|
$-9.13M |
|
-- |
|
-- |
|
-- |
|
0.70 |
|
1.45 |
|
5.49 |
|
66.53 |
|
-73.11% |
|
124.40% |
|
-18.28% |
|
-32.64% |
|
$0.91 |
|
$-0.45 |
|
$-0.45 |
|